A trademark case involving the verbal element CIPRIANI shows that if brand owners wish to maintain their trademark rights, they must demonstrate their use of the mark for each product for which it is registered and for which the plaintiff has proved its interest.
David Aylen
Covid-19 has compounded the Russian government s determination to push on with its localisation agenda and to move quickly on many other healthcare-related initiatives, such as online pharmacies. Gowlings’ comprehensive report, now in its third edition, presents an invaluable status report and extensive review of the trademark aspects of the pharmaceutical industry in Russia today – a market valued at almost $30 billion, according to the recent Deloitte report “Russian Pharmaceutical Trends in 2020”.
With a population of 145 million people, Russia has the world’s 14th largest pharmaceutical market in terms of volume of sales, with almost 8% annual market growth before the pandemic. At the same time, more than 70% of medicines in the commercial sector are imported from abroad.
To print this article, all you need is to be registered or login on Mondaq.com.
A Trade Mark in Russia can be officially recognised as well-known by registration to the Federal Agency of
Intellectual Property (Rospatent) for the status. Applications can
include registered Trade Marks and unregistered well-known
marks.
The first well-known Trade Mark ИЗВЕСТИЯ
(IZVESTIYA in Cyrillic) was registered on 7 April 2000, more than
20 years ago, for a very famous newspaper in Russia. However,
registration of this type of trade mark is quite significant and a
lot of particular evidence is required. At the date of this
article, there are only 214 well-known trade marks in Russia.